IP Library Granted Patent US 9,453,195
Granted Patent B2
US 9,453,195 · App. 14/414,964 · Granted Sep 27, 2016

Non-pathogenic F18

Inventors: John Morris Fairbrother (Saint-Hyacinthe, CA); Éric Nadeau (Otterburn Park, CA); Clarisse Desautels (Saint-Hyacinthe, CA)
Assignee: PREVTEC MICROBIA INC.
C12N1/20A61K35/74C12R1/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,453,195
App. No.
14/414,964
Granted
Sep 27, 2016
Kind
B2
Abstract

There is provided an isolated E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01. There is also provided methods of using this strain for preventing edema disease or diarrhea caused by an F18 pathogenic E. coli infection in an animal.

Claims (18)

1. A method for preventing an F18 pathogenic E. coli intestinal infection in an animal, comprising intestinal delivery to the animal of an effective amount of a live E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01.

2. The method of claim 1 , wherein said intestinal delivery is obtained by oral administration of the live E. coli strain.

3. The method of claim 2 , wherein said live E. coli strain is in lyophilized form.

4. The method of claim 2 , wherein said live E. coli strain is in frozen form.

5. The method of claim 2 , wherein said live E. coli strain is in association with a feed acceptable carrier.

6. The method according to claim 2 , wherein said animal is a pig.

7. A method for preventing edema disease or diarrhea caused by an F18 pathogenic E. coli infection in an animal, comprising intestinal delivery to the animal of an effective amount of a live E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01.

8. The method of claim 7 , wherein said intestinal delivery is obtained by oral administration of the live E. coli strain.

9. The method of claim 8 , wherein said live E. coli strain is in lyophilized form.

10. The method of claim 8 , wherein said live E. coli strain is in frozen form.

11. The method of claim 8 , wherein said live E. coli strain is in association with a feed acceptable carrier.

12. A method according to claim 8 , wherein said animal is a pig.

13. The method according to claim 1 , wherein said amount is within the range of about 5×10 6 to about 3×10 10 CFU per animal.

14. The method according to claim 1 , wherein said amount is of at least 5×10 7 CFU per animal.

15. The method according to claim 7 , wherein said amount is within the range of about 5×10 6 to about 3×10 10 CFU per animal.

16. The method according to claim 7 , wherein said amount is of at least 5×10 7 CFU per animal.

17. The method according to claim 7 , for preventing edema disease caused by an F18 pathogenic E. coli infection in an animal.

18. The method according to claim 7 , for preventing diarrhea caused by an F18 pathogenic E. coli infection in an animal.

Assignments (2)
MERGER Recorded Aug 28, 2020
From: PREVTEC MICROBIA INC
To: ELANCO CANADA LIMITED
Reel/Frame 053633/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2020
From: PREVTEC MICROBIA INC.
To: ELANCO CANADA LIMITED
Reel/Frame 053294/0879 →
Continuity (2)
Provisional Application 61674179 · Jul 20, 2012
Related Publication 20150152377A1 · Jun 4, 2015